weekend postings may inspire some excitement, page-27

H

Just a few questions? Firstly, Visteon will not announce anything to its customers and shareholders at this late stage (remember the release was actually January) saying the new platform is available in calendar 2009 and that their projection is based on audited sales from 2007 to end of November. The rider was placed there because they were projecting Dec sales not that they were hoping to penetrate a potential 16 M market. Remember that this is a new platform. They don't change platforms. One in all in applies so all their customers will be receiving the same system in all the various models from 2009. My reading is that orders will appear for exactly that amount. It is different for Porters and Larsons as some will not need/want a sea cntainer Intevia lock (the fools) and similarly not all doors will be supplied with an Intevia lock of the 5 M that they produce each year but I bet that as the year progresses the availability of a new lock system for about the same money as a traditional lock (and you can guarantee the price will be closely similar) but with the major security enabling features added. They will sweep the market like just about every comparable technology does these days.

As to cost, there is no way that a mass market in cheap fasteners applied to items such as a glove box can sell for $50-100. The price for such fasteners is limited by price sensitivity and so I say again the price for these will be much lower. You have accused me of not being conservative enough and now you want a higher price!

Visteon is one of a multitude of customers waiting to use the second generation devices for the mass market. Add the other Auto Tier 1 manufacturers in the next months or a little longer and the enormous range of sales that will go into the computing area and as you say the mind boggles. There will be several hundred million annual sales of the cheaper devices and let's say they are only $10 for $5 profit (just for the exercise). Add your pe and do your own sums.

From what I am hearing about the response from DCW, we won't be disappointed!!

Stents are an obvious application for SMA. Whether TZ has the time and resource to concentrate much on high end high margin applications when they are struggling under the weight of customer interactions is moot.

The 1st qtr should reveal the tip of this iceberg and I agree that once the dog is released we could easily have updates that you want to see for reinforcement. As I am not selling even at IPO, the current price , the delist offer, the placement price and even the early trade prices are all as nothing compared to where the price will be as the company beds down more commercial relationships, some of which they have said will take 3 years to establish in new platforms. I can wait.